Ken Fisher's position in Viridian Therapeutics is currently worth $9.51M. That's 0.00% of their equity portfolio (418th largest holding). Ken Fisher started to build up the position in Viridian Therapeutics in Q1 2024 and continued to invest until Q1 2025. Since then they sold 27.1k shares. The investor's estimated purchase price is $9.51M, resulting in a loss of 0.1%.